Matches in Wikidata for { <http://www.wikidata.org/entity/Q66041650> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66041650 description "clinical trial" @default.
- Q66041650 description "ensayu clínicu" @default.
- Q66041650 description "klinisch onderzoek" @default.
- Q66041650 description "клінічне випробування" @default.
- Q66041650 name "Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer" @default.
- Q66041650 name "Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer" @default.
- Q66041650 type Item @default.
- Q66041650 label "Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer" @default.
- Q66041650 label "Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer" @default.
- Q66041650 prefLabel "Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer" @default.
- Q66041650 prefLabel "Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer" @default.
- Q66041650 P1132 Q66041650-8B05BB44-CB82-407C-B40A-BA1A494A1DBA @default.
- Q66041650 P1476 Q66041650-5B449943-D169-4531-BC0C-847E5343E908 @default.
- Q66041650 P17 Q66041650-F5E147CE-0BD5-4E8D-9AF2-4069E93C35FA @default.
- Q66041650 P1813 Q66041650-ED111C4F-551B-4C4F-A917-A1FDEF8EDE75 @default.
- Q66041650 P2899 Q66041650-D2B93FBB-1676-4BE9-8879-E2EC98C1D325 @default.
- Q66041650 P3098 Q66041650-961CAF0F-638F-41DC-B4C6-1BF301EC58DB @default.
- Q66041650 P31 Q66041650-7C8485E9-F6D4-4DEB-8AC0-F5CB6D81D9DE @default.
- Q66041650 P4844 Q66041650-B8B301C4-FBD5-4C67-84F9-0016CE25D399 @default.
- Q66041650 P580 Q66041650-76C71536-5F37-43C9-9051-84CD17850674 @default.
- Q66041650 P582 Q66041650-9F9894C3-BC03-4045-9940-77921BC2487B @default.
- Q66041650 P6099 Q66041650-FAFD4DCA-8CAC-4663-8F39-F6CC1397EC8B @default.
- Q66041650 P6153 Q66041650-17B64D76-C272-45B4-89F7-64C13CFFF572 @default.
- Q66041650 P6153 Q66041650-1BCED5AD-EA61-471C-9255-787E94D1EE53 @default.
- Q66041650 P6153 Q66041650-1D0CE33E-0623-48F4-847B-C71A90FE436A @default.
- Q66041650 P6153 Q66041650-2A4AAF9F-18A6-48F3-AB04-785A77644383 @default.
- Q66041650 P6153 Q66041650-3C8E8D73-4494-4E7F-B01B-32A6D1535DC0 @default.
- Q66041650 P6153 Q66041650-43EFEC9D-B017-4793-BEEA-822514BAAE09 @default.
- Q66041650 P6153 Q66041650-4AFB1E59-FEA6-4C44-A159-F4B927210BD5 @default.
- Q66041650 P6153 Q66041650-4E4E7D08-108C-4D89-B23A-44028B9456F5 @default.
- Q66041650 P6153 Q66041650-9599609D-C44B-40EF-BECC-086DBA7D74D4 @default.
- Q66041650 P6153 Q66041650-A2497C32-838E-40D3-9FD2-D85579369A71 @default.
- Q66041650 P6153 Q66041650-BF9635A2-8BB9-43C0-ABE6-588AEA8100A1 @default.
- Q66041650 P6153 Q66041650-D455ABE4-4658-49C0-965F-1057920F6D70 @default.
- Q66041650 P8363 Q66041650-089A8D73-6C32-4BB6-AEAF-B6F90C4C3294 @default.
- Q66041650 P1132 "+118" @default.
- Q66041650 P1476 "Multicenter Randomized Phase II Study Comparing the Effectiveness and Tolerance of Avelumab Versus Standard 2nd Line Treatment Chemotherapy in Patients With Colorectal Metastatic Cancer With Microsatellite Instability (MSI)" @default.
- Q66041650 P17 Q142 @default.
- Q66041650 P1813 "SAMCO" @default.
- Q66041650 P2899 "+18" @default.
- Q66041650 P3098 "NCT03186326" @default.
- Q66041650 P31 Q30612 @default.
- Q66041650 P4844 Q413299 @default.
- Q66041650 P580 "2018-04-24T00:00:00Z" @default.
- Q66041650 P582 "2024-02-28T00:00:00Z" @default.
- Q66041650 P6099 Q42824440 @default.
- Q66041650 P6153 Q1131080 @default.
- Q66041650 P6153 Q212646 @default.
- Q66041650 P6153 Q2451973 @default.
- Q66041650 P6153 Q2944832 @default.
- Q66041650 P6153 Q2945710 @default.
- Q66041650 P6153 Q2945751 @default.
- Q66041650 P6153 Q30273611 @default.
- Q66041650 P6153 Q30296137 @default.
- Q66041650 P6153 Q3145366 @default.
- Q66041650 P6153 Q50036407 @default.
- Q66041650 P6153 Q50036603 @default.
- Q66041650 P6153 Q89798279 @default.
- Q66041650 P8363 Q78089383 @default.